21.10Class

21.10 Manufacture of basic pharmaceutical products

Financial AggregatesFY 2024

€323,262,958

Total Revenue

Employees

€504,972,202

Total Assets

€373,967,850

Total Equity

10.8%

Profit Margin

9.3%

ROE

€113,825

Revenue / Employee

€41,407

Median Revenue

Median Employees

€336,583

Median Assets

€141,275

Median Equity

1.8%

Median Profit Margin

-1.0%

Median ROE

#	Company	Total Revenue	Employees	Profit Margin
1	Akciju sabiedrība "GRINDEKS"	€181,822,263	1K	-1.8%
2	Akciju sabiedrība "Olpha"	€126,874,000	1K	30.5%
3	Sabiedrība ar ierobežotu atbildību "PHARMIDEA"	€8,554,000	119	2.3%
4	Sabiedrība ar ierobežotu atbildību "BALTIJAS TERAPEITISKAIS SERVISS"	€3,805,555	9	5.4%
5

Showing 1–18 of 18 companies

#	Company	Regcode	Type	Year
1	Akciju sabiedrība "GRINDEKS"	40003034935	AS	2024
2	Akciju sabiedrība "Olpha"	40003007246	AS	2024
3	"PharmIdea Global" SIA	40203431634	SIA	2024
4	Sabiedrība ar ierobežotu atbildību "BALTIJAS TERAPEITISKAIS SERVISS"	40003174110	SIA	2024
5	Sabiedrība ar ierobežotu atbildību "BOGMARKS"	40003895848

NACE Rev.2/2.1, VID tax data 2022–2024